Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/4/12 → 3/31/18 |
Funding
- PaxVax Incorporated: $506,578.00
12-ID-192: A Phase 1 Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD103-HgR
- Greenberg, Richard (PI)